3/30/2009 | PP | Nanogen in default on convertible notes; holders want $29 million
|
11/18/2008 | PP | Nanogen need not comply with milestone required under convertibles agreements
|
8/15/2008 | PP | Market Commentary: Nanogen arranges $5 million for merger, shares decline; Sacre-Coeur wraps C$4.13 million placement
|
8/15/2008 | PP | New Issue: Nanogen plans $5 million placement of convertible bridge notes
|
3/14/2008 | CV | Nanogen to issue 9.75% convertibles in exchange for 6.25% convertibles
|
8/27/2007 | PP | New Issue: Nanogen closes $20 million direct offering of convertible notes and warrants
|
8/27/2007 | PP | Market Commentary: Nanogen announces $20 million convertibles; Distributed Systems settles $15 million convertibles
|
7/26/2007 | CV | Nanogen files $50 million shelf
|
5/25/2007 | CVHY | Nanogen files $50 million stock, debt securities shelf
|
4/4/2007 | SS | Market Commentary: Ameristar falls on deal; Borders rebounds; BioVeris skyrockets; Nanogen zooms; lenders lower
|
4/4/2007 | SS | Market Commentary: Ameristar falls on deal; Borders rebounds; BioVeris skyrockets; Nanogen zooms; lenders lower
|
3/26/2007 | SS | Market Commentary: Biosite buyout lifts diagnostics firms; Rotech rises; Tribune up; Riviera gains; LSI, Agere slump
|
2/5/2007 | PP | Market Commentary: Cell Genesys grabs $75 million equity line; Enzo secures $15 million from stock offering
|
2/5/2007 | PP | New Issue: Nanogen raises $7.57 million from direct placement of stock
|
11/1/2006 | BT | Nanogen revenues double for the quarter to $7.5 million
|
8/24/2006 | BT | Nanogen awarded six patents for use of biomarkers in diabetes, Alzheimer's disease
|
8/23/2006 | BT | American Bio Medica to supply rapid drugs of abuse tests to Nanogen under supply agreement
|
8/3/2006 | BT | Nanogen, Fisher expand molecular diagnostics collaboration
|
7/13/2006 | BT | Nanogen adds real-time PCR reagents to detect varicella zoster virus, Bordetella bacteria
|
5/15/2006 | BT | Nanogen, Jurilab to identify, validate genetic markers for type 2 diabetes
|
5/10/2006 | BTPP | New Issue: Nanogen obtains $25 million equity line
|
4/25/2006 | BT | Nanogen adds EBV-detecting real-time probes and primers to portfolio
|
4/20/2006 | BT | Nanogen to acquire Amplimedical in €8.1 million deal
|
4/17/2006 | BT | Nanogen gets patents for therapeutic, diagnostic biomarkers
|
3/29/2006 | BT | Nanogen gets FDA clearance of StatusFirst test for congestive heart failure
|
3/23/2006 | BT | Nanogen launches cystic fibrosis analyte specific reagents
|
3/17/2006 | BT | Market Commentary: Sunesis stock leaps 11.4% on $45 million PIPE; Salix's stock drops on FDA approval of OsmoPrep
|
3/16/2006 | BT | Fisher Scientific to acquire Athena, percentage of Nanogen
|
3/16/2006 | BTPP | New Issue: Nanogen to close $15 million direct placement of stock
|
1/18/2006 | BT | Nanogen, Princeton Biomeditech sign joint development pact
|
12/22/2005 | BT | Nanogen receives patents for genetic analysis technologies
|
12/20/2005 | BT | Nanogen to acquire Spectral's rapid cardiac immunoassay test business for C$9 million
|
11/17/2005 | BT | Nanogen's synthesis of pyrazolopyrimidine to develop diagnostic assays receives patent
|
9/28/2005 | PP | Market Commentary: Fairfax Financial raises $300 million from direct placement; direct deals, convertibles popular
|
9/28/2005 | BTPP | New Issue: Nanogen completes $19.99 million direct placement of stock
|
6/20/2005 | BTCV | Nanogen files $60 million shelf
|